Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 32,667,000 | 31,376,000 | 30,328,000 | 29,324,000 | 34,114,000 |
| Cost of Goods | 9,017,000 | 9,048,000 | 8,565,000 | 9,554,000 | 11,603,000 |
| Gross Profit | 23,650,000 | 22,328,000 | 21,763,000 | 19,770,000 | 22,511,000 |
| Operating Expenses | 15,312,000 | 16,786,000 | 14,418,000 | 13,041,000 | 15,828,000 |
| Operating Income | 8,338,000 | 5,542,000 | 7,345,000 | 6,729,000 | 6,683,000 |
| Interest Expense | 687,000 | 640,000 | 725,000 | 826,000 | 777,000 |
| Other Income | -250,000 | -1,425,000 | -556,000 | -275,000 | -464,000 |
| Pre-tax Income | 7,401,000 | 3,477,000 | 6,064,000 | 5,628,000 | 5,442,000 |
| Income Tax | 1,112,000 | 526,000 | 756,000 | 707,000 | 346,000 |
| Net Income Continuous | 6,289,000 | 2,951,000 | 5,308,000 | 4,921,000 | 5,096,000 |
| Net Income Discontinuous | N/A | 0 | 0 | 10,700,000 | N/A |
| Minority Interests | -573,000 | -376,000 | -380,000 | -665,000 | -711,000 |
| Net Income | $5,716,000 | $2,575,000 | $4,928,000 | $14,956,000 | $4,385,000 |
| EPS Basic Total Ops | N/A | 0.63 | 1.22 | 3.71 | 1.10 |
| EPS Basic Continuous Ops | N/A | 0.63 | 1.22 | 1.11 | 1.10 |
| EPS Basic Discontinuous Ops | N/A | 0.00 | 0.00 | 2.61 | N/A |
| EPS Diluted Total Ops | N/A | 0.62 | 1.20 | 3.66 | 1.08 |
| EPS Diluted Continuous Ops | N/A | 0.62 | 1.20 | 1.09 | 1.08 |
| EPS Diluted Discontinuous Ops | N/A | 0.00 | 0.00 | 2.57 | N/A |
| EBITDA(a) | $10,402,000 | $6,668,000 | $9,083,000 | $8,601,000 | $8,596,000 |